Book Online

Appointment Request

Appointment Request

"*" indicates required fields

Are you a new or returning patient?*
Full Name*
MM slash DD slash YYYY
Sex*
This field is for validation purposes and should be left unchanged.

Book Online

Appointment Request

Appointment Request

"*" indicates required fields

Are you a new or returning patient?*
Full Name*
MM slash DD slash YYYY
Sex*
This field is for validation purposes and should be left unchanged.

COVID-19 Updates

COVID-19 Updates: Stay Informed with the Latest Information

Stay up-to-date with our latest COVID-19 updates page, providing essential information and guidance to keep you informed and safe during these unprecedented times.

COVID-19 Update # 8

As of 4-5-22, the use of Sotrovimab- Monoclonal autobody infusion is no longer authorized by the FDA in the USA...
Read More

COVID-19 Update # 7

Now Available - SOTROVIMAB- Monoclonal antibody infusion for treatment of high risk patients with COVID -19 omicron variant infection.
Read More

COVID-19 Update # 6

NC-DOH Calls for a cease of administration of REGEN-COV and other Monoclonal Antibodies secondary to Omicron Variant starting 12-27-2021.
Read More

COVID-19 Update # 5

Now available at Ballantyne Medical Associates®®:Regeneron REGEN-COV Monoclonal Antibodies for the Early Outpatient Treatment & Post Exposure Prophylaxis of SARS-CoV-2...
Read More

COVID-19 Update # 4 / Vaccine Clinic 3-2-2022

We believe that most individuals either not previously COVID-19 infected, those previously COVID-19 infected, and those COVID-19 Vaccinated WILL become infected with the highly contagious Variant, or some other yet to...
Read More

COVID-19 Update # 3

The convenience and same day easy access protocol provided by our Walk In Clinic, which our patients have grown accustomed,...
Read More
Scroll to Top

Appointment Request

Appointment Request

"*" indicates required fields

Are you a new or returning patient?*
Full Name*
MM slash DD slash YYYY
Sex*
This field is for validation purposes and should be left unchanged.